ATP synthase subunit c (atpE) is a membrane-spanning component of the F₀ sector, responsible for proton translocation across the bacterial cytoplasmic membrane. This process drives ATP synthesis by coupling proton motive force (PMF) to ADP phosphorylation. In Salmonella, subunit c oligomerizes to form a ring structure that facilitates proton flow, a mechanism conserved across Gram-negative bacteria .
Subunit c interacts with virulence factors like MgtC, a magnesium-responsive protein that represses biofilm formation by inhibiting ATP synthase activity. Elevated ATP levels in mgtC mutants increase cyclic diguanylate (c-di-GMP), promoting cellulose biosynthesis and biofilm formation. This mechanism reduces intracellular replication efficiency and virulence in macrophages, as biofilms interfere with host cell invasion .
MgtC-mediated inhibition of ATP synthase lowers cytosolic ATP, suppressing bcsA (cellulose synthase) expression.
Cellulose overproduction in mgtC mutants reduces virulence in mice, highlighting the trade-off between biofilm formation and pathogenicity .
Subunit c is a validated target for novel antimicrobials. Small-molecule inhibitors (e.g., diarylquinolines) bind directly to the F₀ sector, disrupting ATP synthesis. Resistance arises from mutations in atpE, such as V48I and V60A, which confer a >100-fold increase in minimum inhibitory concentration (MIC) for Streptococcus pneumoniae .
| Mutation | MIC Increase | Species Affected |
|---|---|---|
| V48I | >100-fold | S. pneumoniae |
| V60A | >100-fold | S. pneumoniae |
| V48I+V60A | >100-fold | S. pneumoniae |
Resistance data derived from S. pneumoniae studies .
Recent studies reveal that ATP synthase subunit c may contribute to type-III secretion systems (T3SS) in Salmonella. While ATP hydrolysis by T3SS-associated ATPases (e.g., InvC) is typically required for secretion, mutations that enhance proton motive force bypass this requirement. Subunit c’s role in maintaining PMF suggests a secondary function in supporting effector protein export .
The His-tagged atpE protein is expressed in E. coli and purified via metal affinity chromatography. Stability is ensured through balanced lethal systems (e.g., asd plasmid retention), enabling serial passage without plasmid loss .
Attenuated Salmonella strains (e.g., rSC0016) expressing heterologous antigens (e.g., Pasteurella multocida PlpE) leverage the host immune response. While subunit c is not directly involved in vaccine efficacy, its role in maintaining bacterial viability during antigen delivery is critical .
KEGG: sec:SCH_3782
ATP synthase subunit c (atpE) in Salmonella choleraesuis is a membrane-spanning component of the F₀ sector of ATP synthase. It consists of 79 amino acids and forms an oligomeric structure that creates a channel for proton flow across the cytoplasmic membrane. The amino acid sequence of the protein is MENLNMDLLYMAAAVMMGLAAIGAAIGIGILGGKFLEGAARQPDLIPLLRTQFFIVMGLVDAIPMIAVGLGLYVMFAVA . This subunit is crucial for the proton flow that drives ATP synthesis, as it contains the transmembrane domains that allow protons to pass through the membrane, ultimately powering the catalytic activity of the F₁ portion of the ATP synthase complex.
Recombinant Salmonella choleraesuis atpE can be expressed using several systems. The most common approach involves:
Gene cloning: The atpE gene (typically expression region 1-79) is PCR-amplified and cloned into a suitable expression vector with an appropriate tag (His-tag is commonly used) .
Expression system selection: E. coli BL21(DE3) is frequently used for expressing membrane proteins, though specialized strains designed for membrane protein expression may yield better results.
Optimization of expression conditions: Induction parameters (temperature, IPTG concentration, time) must be optimized to increase protein yield while reducing formation of inclusion bodies.
Membrane protein extraction: Detergent-based extraction (using DDM, LDAO, or similar detergents) is typically employed to solubilize the membrane-embedded atpE.
Purification: Affinity chromatography (based on the tag used), followed by size exclusion chromatography to achieve high purity.
The purified protein is typically stored in a Tris-based buffer with 50% glycerol at -20°C or -80°C to maintain stability .
ATP synthase subunit c plays a critical role in Salmonella choleraesuis pathogenicity through several mechanisms:
Energy provision: By facilitating ATP production, atpE supports the energy requirements for virulence factor expression and bacterial replication within host cells.
pH homeostasis: ATP synthase, including the c subunit, contributes to pH regulation in Salmonella, which is crucial for survival in the acidic environment of phagosomes .
Interaction with virulence proteins: The MgtC virulence protein in Salmonella interacts with the F₁F₀ ATP synthase complex (which includes atpE), inhibiting its activity to reduce ATP levels . This reduction prevents excessive cyclic diguanylate production, thereby repressing cellulose biosynthesis, which would otherwise interfere with intracellular replication.
Adaptation to intraphagosomal environment: ATP synthase activity modulation helps Salmonella adapt to the nutrient-limited conditions inside phagosomes, supporting intracellular survival and replication.
Research shows that disruption of proper ATP synthase function can significantly alter virulence properties, indicating that atpE and other ATP synthase components are potential targets for anti-virulence strategies.
The relationship between ATP synthase activity and biofilm formation in Salmonella involves a complex regulatory network:
ATP levels and c-di-GMP: ATP synthase activity directly influences intracellular ATP concentration, which affects cyclic diguanylate (c-di-GMP) levels, a second messenger that promotes biofilm formation .
MgtC-mediated regulation: The virulence protein MgtC inhibits ATP synthase activity, thereby reducing ATP levels and preventing a rise in c-di-GMP . This mechanism represents a virulence strategy to repress biofilm formation during infection.
Cellulose production: Elevated ATP levels in an mgtC mutant resulted in a sevenfold increase in bcsA mRNA (encoding cellulose synthase), leading to increased cellulose production . This was confirmed when expressing the α, β, and γ components of the F₁ subunit of ATP synthase prevented cellulose production in the mgtC mutant.
Impact on virulence: Cellulose, a major structural component of Salmonella biofilms, interferes with replication inside macrophages and virulence in mice . By regulating ATP synthase activity, Salmonella can modulate biofilm formation to optimize its virulence.
This data suggests that ATP synthase subunit c, as part of the ATP synthase complex, plays an indirect but significant role in biofilm regulation through its primary function in ATP synthesis.
The relationship between atpE function and type-III protein secretion systems (T3SS) in Salmonella involves energy coupling mechanisms:
Shared energy requirements: Both ATP synthase and T3SS utilize the proton motive force (PMF) across the bacterial membrane. ATP synthase uses PMF to generate ATP, while T3SS uses it directly for protein export .
ATP-independent secretion: Research has shown that type-III protein secretion can occur in the absence of type-III ATPase activity when the proton motive force is increased . This suggests that ATP hydrolysis is not absolutely required for T3SS function if sufficient PMF is available.
Evolutionary implications: The finding that T3SS can function without ATP hydrolysis suggests that a proto-ATPase was likely added to a primordial proton-powered export system during evolution to enhance secretion efficiency . This has implications for understanding both ATP synthase and T3SS evolution.
Metabolic coordination: Both systems must be metabolically coordinated during infection, as energy utilization must be balanced between virulence factor secretion and cellular energy maintenance.
Understanding the interplay between these systems provides insights into bacterial adaptation mechanisms during infection and may reveal potential targets for therapeutic intervention.
The study of interactions between atpE and potential inhibitors can be approached through multiple complementary methods:
Biochemical assays:
ATP synthesis assays using inverted membrane vesicles to measure IC₅₀ values of inhibitors
ATP hydrolysis assays to determine the effect on the reverse reaction
Proton translocation assays to directly assess the impact on c-ring function
Structural biology approaches:
X-ray crystallography or cryo-EM of the ATP synthase c-ring in complex with inhibitors
NMR studies of labeled recombinant atpE with various inhibitors
Molecular docking and in silico modeling to predict binding sites
Resistance mutation analysis:
Selection of resistant mutants at 5× and 50× MIC concentrations
Whole-genome sequencing to identify mutations in the atpE gene
Site-directed mutagenesis to confirm the role of specific residues in inhibitor binding
Cellular assays:
Membrane potential measurements using fluorescent probes
Determination of intracellular ATP levels following inhibitor treatment
Growth inhibition assays under various metabolic conditions
Research has shown that compounds targeting ATP synthase subunit c typically show IC₅₀ values between 1-3 μg/ml in biochemical assays, which correlate well with MIC values in whole-cell screening assays .
To investigate atpE's role in bacterial persistence and antibiotic tolerance, researchers can employ the following methods:
Genetic approaches:
Construction of atpE conditional expression strains using inducible promoters
Site-directed mutagenesis of key residues to create partially functional variants
Gene knockdown studies using antisense RNA or CRISPR interference
Persistence assays:
Time-kill curves in the presence of bactericidal antibiotics
Determination of persister cell frequencies after antibiotic treatment
Microscopy-based single-cell analysis of bacterial subpopulations
Metabolic analysis:
Measurement of ATP/ADP ratios in persister vs. non-persister populations
Membrane potential analysis using voltage-sensitive dyes
Oxygen consumption and proton translocation rates in different growth phases
Transcriptomic and proteomic studies:
RNA-seq analysis comparing wild-type and atpE variant strains
Proteomics to identify interaction partners during persistence
ChIP-seq to identify regulators of atpE expression
In vivo models:
Animal infection models to assess bacterial persistence
Tissue colonization studies comparing wild-type and atpE variants
Antibiotic treatment efficacy in established infections
These approaches help elucidate how ATP synthase activity modulation contributes to bacterial survival under stress conditions and antibiotic exposure.
Developing atpE-targeting antimicrobials specific for Salmonella faces several technical challenges:
Selectivity issues:
ATP synthase is highly conserved across bacterial species and mitochondria
Achieving specificity for Salmonella requires targeting unique structural features
Studies show that diarylquinolines targeting ATP synthase have selectivity indices (SI) >10 for S. aureus vs. mitochondria, but designing Salmonella-specific compounds is more challenging
Membrane penetration:
Gram-negative bacteria like Salmonella have an outer membrane that limits compound entry
E. coli studies suggest that limited uptake through the Gram-negative cell membrane contributes to resistance to ATP synthase inhibitors
Compounds need specific physicochemical properties to penetrate both membranes
Efflux mechanisms:
Polymorphisms in target:
Testing limitations:
Standard antimicrobial susceptibility testing may not reflect in vivo efficacy
Metabolic dependency on ATP synthase varies with growth conditions
Specialized assays are needed to evaluate compound efficacy in relevant conditions
These challenges highlight the need for structure-based rational drug design approaches and combination strategies to develop effective atpE-targeting antimicrobials for Salmonella.
Recombinant atpE can be employed in vaccine development against Salmonella choleraesuis through several strategic approaches:
Subunit vaccine development:
Recombinant atpE can be formulated with appropriate adjuvants to stimulate specific immune responses
The conserved nature of atpE may provide cross-protection against multiple Salmonella serovars
Epitope mapping can identify immunogenic regions for focused immune responses
Live attenuated vaccine vectors:
Prime-boost strategies:
Initial priming with attenuated Salmonella expressing recombinant atpE followed by boosting with purified protein
This approach has been successful with other antigens, as demonstrated by studies using attenuated S. Typhimurium ΔznuABC and inactivated S. Choleraesuis vaccine
The strategy enhances both cellular and humoral immune responses
DNA vaccine approaches:
Plasmid DNA encoding atpE can stimulate both antibody production and cell-mediated immunity
DNA vaccines can be followed by protein boosts to enhance immunogenicity
The technique allows for co-delivery of immunostimulatory molecules
Immunological evaluation:
Assessment of both humoral and cell-mediated immune responses is essential
Protection evaluation through challenge studies in appropriate animal models
Correlates of protection should be established to predict vaccine efficacy
The utilization of recombinant atpE in vaccine approaches must consider factors such as protein conformation, stability, and presentation to the immune system for optimal efficacy.
ATP synthase inhibition represents a promising strategy against multidrug-resistant Salmonella for several key reasons:
Novel mechanism of action:
ATP synthase inhibitors act through a mechanism distinct from conventional antibiotics
This reduces the likelihood of cross-resistance with existing antimicrobials
ATP synthase function is essential under many growth conditions, making it a vulnerability
Metabolic vulnerability:
ATP synthesis inhibition leads to energy depletion and bacterial growth arrest
Studies have shown that blocking respiratory ATP synthesis causes depletion of cellular ATP levels and bacterial killing
The central role of ATP synthase in energy metabolism creates a high barrier to resistance development
Synergistic potential:
ATP synthase inhibitors can potentially sensitize resistant bacteria to traditional antibiotics
Energy depletion may compromise efflux pump function, reducing the expulsion of other antibiotics
Combination therapy approaches may reduce resistance development
Target validation:
Challenges to consider:
Selectivity over mammalian ATP synthase requires careful inhibitor design
Salmonella's Gram-negative cell envelope may limit inhibitor access to the target
Potential metabolic adaptation mechanisms must be addressed
| Compound Type | ATP Synthesis IC₅₀ (μg/ml) in S. aureus | IC₅₀ in E. coli | IC₅₀ in Mitochondria | Selectivity Index |
|---|---|---|---|---|
| Diarylquinolines (1) | 1.4 ± 0.5 | 7 ± 0.4 | 29 ± 2 | >10 |
| Diarylquinolines (2) | 2.5 ± 0.7 | 8 ± 0.6 | 27 ± 1.6 | >10 |
| Diarylquinolines (3) | 2.7 ± 0.1 | 9 ± 0.6 | 23 ± 2.2 | >10 |
| DCCD | 0.9 ± 0.2 | 1 ± 0.1 | 0.2 ± 0.01 | <1 |
| Oligomycin | 5.6 | 7 ± 0.7 | 6 ± 0.6 | ≈1 |
This data indicates that selective ATP synthase inhibitors can be developed with sufficient therapeutic windows compared to typical non-selective inhibitors like DCCD and oligomycin .
ATP synthase subunit c (atpE) functions in a broader energetic context that relates to ATPase-independent type-III protein secretion through several mechanisms:
Proton motive force generation and utilization:
Evolutionary relationships:
The cytoplasmic components of the type-III secretion system share strong homology with F₀F₁ ATP synthase
It is proposed that the flagellum was derived from a proto F₀F₁-ATP synthase
The finding that ATPase activity is dispensable for type-III secretion suggests that a proto-ATPase was added to a primordial proton-powered export system during evolution
Energetic adaptation during infection:
During infection, Salmonella must balance energy production and utilization
ATP synthase and type-III secretion systems must be coordinately regulated
The ability to use PMF directly for protein secretion may conserve ATP for other essential processes
Experimental evidence:
Functional flagella can form in the absence of type-III ATPase activity when mutations increase PMF and flagellar substrate levels
Increased PMF can bypass the requirement of the Salmonella pathogenicity island 1 virulence-associated type-III ATPase for secretion
This indicates that type-III ATPases primarily enhance secretion efficiency under limited substrate concentrations
This research reveals an important principle: ATP synthase and type-III secretion systems share fundamental mechanisms of energy coupling to membrane transport, with important implications for understanding bacterial physiology and developing targeted interventions.
Several cutting-edge technologies are poised to revolutionize our understanding of atpE structure-function relationships:
Cryo-electron microscopy advancements:
High-resolution structures of the complete ATP synthase complex with bound inhibitors
Visualization of conformational changes during the catalytic cycle
Structural comparison of wild-type and mutant forms associated with inhibitor resistance
Single-molecule techniques:
Real-time visualization of proton translocation through the c-ring
Direct measurement of c-ring rotation during ATP synthesis
Force measurements to determine the energetics of the process
Advanced computational methods:
Molecular dynamics simulations of the entire ATP synthase in a lipid bilayer environment
Machine learning approaches to predict functional consequences of atpE mutations
Quantum mechanical calculations to understand proton transfer mechanisms
Genetic tools:
CRISPR-Cas9 base editing for precise modification of key atpE residues
In vivo deep mutational scanning to comprehensively map structure-function relationships
Synthetic biology approaches to construct minimal or modified ATP synthase complexes
Imaging technologies:
Super-resolution microscopy to visualize ATP synthase distribution in bacterial membranes
Correlative light and electron microscopy to connect structure and function
Label-free imaging techniques to study ATP synthase in native environments
These technologies will provide unprecedented insights into how atpE contributes to ATP synthase function and how this can be targeted for antimicrobial development.
Research on atpE holds several important implications for cross-species Salmonella vaccine development:
Conserved epitope identification:
Comparative analysis of atpE sequences across Salmonella serovars can identify highly conserved regions
These conserved epitopes may serve as targets for broadly protective immune responses
Structural analysis can determine which epitopes are accessible to the immune system
Integration with attenuated vaccine strains:
Attenuated Salmonella strains (e.g., S. Typhimurium ΔznuABC) show promise as vaccine vectors
These strains could be engineered to express modified atpE proteins with enhanced immunogenicity
Prime-boost protocols combining attenuated live vaccines with inactivated vaccines have shown efficacy against S. Choleraesuis
Host-pathogen interaction insights:
Understanding how atpE contributes to Salmonella survival in different host species
Identifying atpE modifications that optimize immune recognition while maintaining immunogenicity
Correlating immune responses to atpE with protection across different host species
Adjuvant development:
ATP synthase components might serve as natural adjuvants due to their conserved nature
Specific fragments of atpE could enhance immune responses to co-administered antigens
Novel formulations combining atpE with other immunomodulators may enhance vaccine efficacy
One Health applications:
Cross-species vaccines could reduce Salmonella prevalence in animal reservoirs
This approach aligns with One Health initiatives to control zoonotic infections
Vaccines effective across species barriers could have significant public health impact
The research on attenuated Salmonella strains as vaccines demonstrates significant progress in this direction, with prime-boost vaccination protocols showing protection against challenge infection in piglets .
Research on ATP synthase subunit c (atpE) provides valuable insights into bacterial adaptation mechanisms:
Energy conservation strategies:
ATP synthase modulation is a key mechanism for adapting to energy-limited environments
Studies show that MgtC-mediated inhibition of ATP synthase helps Salmonella adapt to magnesium-limited conditions
Understanding how bacteria regulate ATP synthase activity could reveal new aspects of stress adaptation
pH homeostasis mechanisms:
Biofilm regulation:
Antimicrobial resistance development:
Cross-talk with stress response systems:
ATP synthase activity likely interfaces with general stress response pathways
Energy status serves as a key input for global regulatory networks
Exploring this cross-talk could reveal how bacteria integrate multiple stress signals
By studying atpE and ATP synthase in the context of stress adaptation, researchers can gain fundamental insights into bacterial physiology that extend beyond energy production to encompass broader aspects of bacterial survival strategies.